Emergence of Clonal Complex 17 Enterococcus faecium in The Netherlands
- 1 January 2008
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (1) , 214-219
- https://doi.org/10.1128/jcm.01351-07
Abstract
The global emergence of vancomycin-resistant Enterococcus faecium has been characterized as the clonal spread of clonal complex 17 (CC17) E. faecium . CC17 was defined upon multilocus sequence typing and is characterized by resistance to quinolones and ampicillin and the presence of the enterococcal surface protein (Esp) in the majority of isolates. The recently noticed increased incidence of vancomycin-susceptible CC17 E. faecium infections in our hospital initiated a nationwide study to determine ecological changes among enterococcal infections. The data and strain collections were obtained from 26 (38%) and 9 (14%) of 66 microbiology laboratories in The Netherlands. E. faecium and E. faecalis were distinguished by multiplex PCR; all E. faecium isolates were genotyped by multiple-locus variable-number tandem-repeat analysis (MLVA), and the presence of esp was identified by PCR. Average numbers of ampicillin-resistant enterococcal isolates from normally sterile body sites per hospital increased from 5 ± 1 in 1994 to 25 ± 21 in 2005. Among all enterococcal bloodstream infections, the proportions of ampicillin-resistant E. faecium (AREF) increased from 4% in 1994 to 20% in 2005 ( P < 0.001). All E. faecalis isolates were susceptible to ampicillin, whereas 78% of the E. faecium isolates were resistant (49% of these contained esp ). Genotyping revealed that 86% of AREF isolates belonged to CC17, including four dominant MLVA types found in ≥3 hospitals, accounting for 64% of the AREF isolates. Infections caused by CC17 E. faecium has increased nationwide, especially in university hospitals due to the clonal spread of four MLVA types, and seems associated with acquisition of the esp gene.Keywords
This publication has 33 references indexed in Scilit:
- Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patientsJournal of Infection, 2007
- Growth Condition-Dependent Esp Expression by Enterococcus faecium Affects Initial Adherence and Biofilm FormationInfection and Immunity, 2007
- Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?Bone Marrow Transplantation, 2006
- Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitalsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Global Spread of Vancomycin-resistantEnterococcus faeciumfrom Distinct Nosocomial Genetic ComplexEmerging Infectious Diseases, 2005
- Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin TherapyAntimicrobial Agents and Chemotherapy, 2005
- Emerging Incidence of Enterococcus faecium among Hospital Isolates (1993 to 2002)Journal of Clinical Microbiology, 2005
- Detection of Oxazolidinone-Resistant Enterococcus faecalis and Enterococcus faecium Strains by Real-Time PCR and PCR-Restriction Fragment Length Polymorphism AnalysisJournal of Clinical Microbiology, 2002
- Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center 1 1Edited by D. E. DraperJournal of Molecular Biology, 1999
- Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United StatesDiagnostic Microbiology and Infectious Disease, 1995